This activation aligns with previous studies associating elevated plasma BCAA concentrations with T2D risk.59,60 Perturbations in BCAA metabolism have been implicated in interfering with insulin and glucose homeostasis, making branched-chain amino acids potential early biomarkers for identifying individuals at risk of developing T2D. This evidence concerns the gene INS and type 2 diabetes mellitus.